全球甲状腺功能检测市场规模（按检测类型、最终用户、应用、地区、范围和预测）

甲状腺功能检测市场规模及预测

2024 年甲状腺功能测试市场规模价值为 19.1 亿美元，预计到 2031 年将达到 29.4 亿美元，2024 年至 2031 年的复合年增长率为 6.10%。

甲状腺功能测试（TFT）是一种检查甲状腺调节新陈代谢和荷尔蒙生成能力的诊断工具。这些检查可检测血液样本中的甲状腺激素（T3 和 T4）、促甲状腺激素 (TSH) 和其他甲状腺相关指标。甲状腺功能测试对于识别甲状腺问题（例如甲状腺功能减退、甲状腺功能亢进和甲状腺结节）至关重要。

甲状腺功能测试在临床上用于评估甲状腺健康状况并追踪甲状腺疾病患者的药物效果。 TFT 也用于新生儿先天性甲状腺功能低下症的筛检，以便儘早发现和治疗。

展望未来，由于全球甲状腺疾病盛行率上升、认识和筛检力度不断加大以及检测技术的进步，甲状腺功能检测市场展现出良好的成长前景。未来的发展可能集中在提高测试准确性、减少週转时间以及扩大 TFT 的应用范围以纳入预测指标和即时诊断测试。随着医疗保健系统向预防医学和个人化药物治疗方向发展，全面甲状腺功能检测的需求可能会上升，从而推动市场成长。

甲状腺功能检测市场动态

主要市场驱动因子

甲状腺疾病发生率不断上升：这主要是由于甲状腺功能减退、甲状腺功能亢进和甲状腺癌等甲状腺疾病在全球范围内的患病率不断上升。随着知识和诊断方法的改进，越来越多的人接受甲状腺疾病检测，增加了对 TFT 的需求。

诊断技术的进步：TFT 市场的扩张受到技术进步的推动，例如更敏感和更具体的测试、自动化测试平台和即时诊断测试选项。这些进步将提高诊断的准确性，减少週转时间并为医疗专业人员和患者提供更大的便利。

人口老化和医疗保健意识：日益增长的老龄化人口更容易患甲状腺疾病，医疗保健意识和筛检计划的不断增加正在推动 TFT 市场的成长。早期检测和定期监测甲状腺功能已成为一种常见的程序，从而推动了这些测试的市场需求。

主要问题：

测试结果和解释的多变性：TFT 可能受到许多变数的影响，包括药物、疾病和怀孕，导致测试结果的多变性。必须仔细解释这些数据，考虑到患者的病史和临床情况，以避免误诊和不适当的治疗。

成本限制和报销问题：TFT 和相关诊断程序的成本对于某些患者和医疗保健系统来说可能过高。各种测试的报销政策和覆盖范围限制为寻求完整甲状腺健康评估的临床医生和患者带来了财务障碍。

监管和合规课题：TFT 市场的製造商和医疗保健提供者面临着遵守监管要求和不断发展的诊断测试程序的课题。确保遵守品质标准、获得相关认证以及跨多个地点协商监管变化可能是一项耗费资源且耗时的任务。

主要趋势：

采用先进的测试技术：在 TFT 中，使用高度敏感和特定的检测、自动化测试平台和分子诊断正变得越来越普遍。这些先进的技术提高了诊断的准确性，缩短了周转时间，并提高了甲状腺功能测试的整体效率。

即时诊断检测 (POCT) 的整合：即时诊断检测越来越多地被用于测量甲状腺功能。 POCT 可以进行快速、现场测试，产生即时数据并实现更快地临床决策。这种趋势在偏远和资源有限的环境中以及持续患者监测中特别有用。

重视预防医学和早期诊断：人们越来越重视甲状腺疾病的预防医学和早期发现。由于宣传力度加大、定期筛检计画以及主动健康检查，越来越多的人接受了甲状腺功能检查。这一趋势源于人们认识到早期发现和治疗甲状腺问题可以显着改善患者的预后。

目录

第 1 章简介

• 市场定义
• 市场区隔
• 研究方法

第 2 章执行摘要

• 主要发现 市场概况 市集亮点

第三章 市场概览

• 市场规模与成长潜力
• 市场趋势
• 市场推动因素
• 市场限制
• 市场机会
• 波特五力分析

第 4 章。

• 促甲状​​腺激素（TSH）测试
• T4（甲状腺素）测试
• T3（三碘甲状腺原氨酸）测试
• 甲状腺抗体检测

第 5 章 甲状腺功能检测市场（依最终用户划分）

• 医院
• 诊断实验室
• 研究机构

第六章 甲状腺功能检测市场（依应用）

• 甲状腺功能低下症
• 甲状腺功能亢进
• 甲状腺结节
• 甲状腺癌

第 7 章 区域分析

• 北美洲
• 美国
• 加拿大
• 墨西哥
• 欧洲
• 英国
• 德国
• 法国
• 义大利 亚太地区
• 中国
• 日本
• 印度
• 澳大利亚
• 拉丁美洲
• 巴西
• 阿根廷
• 智利
• 中东和非洲
• 南非
• 沙乌地阿拉伯
• 阿拉伯联合大公国

第 8 章 市场动态

• 市场推动因素
• 市场限制
• 市场机会
• COVID-19 对市场的影响

第 9 章 竞争格局

• 大型公司
• 市占率分析

第十章 公司简介

• Abbott Laboratories
• Siemens Healthineers AG
• Danaher Corporation
• Roche Diagnostics
• Thermo Fisher Scientific
• Meridian Bioscience, Inc.
• Beckman Coulter Inc.
• Omega Diagnostics Group plc
• Bio-Rad Laboratories, Inc.

第 11 章 市场展望与机会

• 新兴技术
• 未来市场趋势
• 投资机会

第 12 章附录

• 缩写列表
• 来源与参考文献

Thyroid Function Test Market Size And Forecast

Thyroid Function Test Market size was valued at USD 1.91 Billion in 2024 and is projected to reach USD 2.94 Billion by 2031, growing at a CAGR of 6.10% from 2024 to 2031.

Thyroid function tests (TFTs) are diagnostic tools that examine the thyroid gland's ability to regulate metabolism and hormone production. These tests detect thyroid hormones (T3 and T4), thyroid-stimulating hormone (TSH) and other thyroid-related indicators in blood samples. TFTs are essential for identifying thyroid problems such as hypothyroidism, hyperthyroidism and thyroid nodules.

Thyroid function tests are used in clinical diagnostics to assess thyroid health and track medication efficacy in individuals with thyroid disorders. TFTs are also used to screen neonates for congenital hypothyroidism which allows for early detection and management.

Looking ahead, the thyroid function test market exhibits excellent growth prospects owing to rising rates of thyroid illnesses worldwide, increased awareness and screening activities and advancements in testing technology. Future advancements may concentrate on improving test accuracy shortening turnaround times and broadening the application of TFTs to incorporate predictive indicators or point-of-care testing. As healthcare systems promote preventive care and individualized medication, the demand for comprehensive thyroid function testing is likely to rise fueling market growth.

Thyroid Function Test Market Dynamics

The key market dynamics that are shaping the global thyroid function test market include:

Key Market Drivers:

Increasing Incidence of Thyroid Disorders: The increased global prevalence of thyroid problems such as hypothyroidism, hyperthyroidism and thyroid cancer are the major factors. As knowledge and diagnostic methods improve, more people are being checked for thyroid dysfunction which increases demand for TFTs.

Technological Advances in Diagnostic Technologies: TFT market expansion is being driven by technological advancements such as more sensitive and specific assays, automated testing platforms and point-of-care testing choices. These advancements improve diagnostic accuracy, shorten turnaround times and increase convenience for both healthcare personnel and patients.

Aging Population and Healthcare Awareness: The growing aging population which is more susceptible to thyroid diseases together with increased healthcare awareness and screening programs adds to the TFT market's growth. Early detection and regular monitoring of thyroid function have become common procedures driving up market demand for these tests.

Key Challenges:

Variability in Test Findings and Interpretation: TFTs can be affected by a variety of variables including drugs, sickness and pregnancy resulting in variable test findings. To avoid misdiagnosis or inappropriate therapies, these data must be interpreted carefully taking into account the patient's history and clinical situation.

Cost Constraints and Reimbursement Issues: The cost of TFTs and accompanying diagnostic procedures may be prohibitively expensive for some patients and healthcare systems. Reimbursement policies and coverage constraints for various tests differ creating financial hurdles for both clinicians and patients seeking a full thyroid health assessment.

Regulatory and Compliance Challenges: Manufacturers and healthcare providers in the TFT market face challenges in adhering to regulatory requirements and evolving diagnostic testing procedures. Ensuring compliance with quality standards getting relevant certifications and negotiating regulatory changes across multiple locations can be resource-intensive and time-consuming.

Key Trends:

Adoption of Advanced Testing Technologies: In TFTs, the use of extremely sensitive and specific assays, automated testing platforms and molecular diagnostics is becoming increasingly common. These sophisticated technologies improve diagnostic accuracy shorten turnaround times and increase overall efficiency in thyroid function testing.

Integration of Point-of-Care Testing (POCT): Point-of-care testing is increasingly being used to measure thyroid function. POCT provides for rapid, on-site testing resulting in instant data and faster clinical decision-making. This trend is especially useful in remote or resource-limited environments as well as for continuous patient monitoring.

Focus on Preventive Care and Early Diagnosis: There is an increasing emphasis on preventive care and early detection of thyroid diseases. Increased awareness efforts, regular screening programs and proactive health check-ups are encouraging more people to have their thyroid function tested. This tendency stems from the realization that early detection and treatment of thyroid problems can considerably enhance patient outcomes.

Global Thyroid Function Test Market Regional Analysis

Here is a more detailed regional analysis of the global thyroid function test market:

North America:

According to Verified Market Research analyst, North America is expected to dominate the global thyroid function test market.

The region's dominance is due to the widespread availability of thyroid function tests and the presence of trained healthcare professionals. The region's excellent healthcare infrastructure makes diagnostic facilities accessible and healthcare providers are well-trained to deliver and interpret these tests correctly. This accessibility and knowledge help increase the widespread use and reliability of TFTs, resulting in industry development.

Furthermore, the required screening of newborns for congenital hypothyroidism greatly boosts the market. Early discovery through these screens allows for timely care lowering the risk of developmental difficulties linked with thyroid abnormalities. Furthermore, cost-effective technologies for screening thyroid cancer are driving the market. Affordable and efficient diagnostic solutions promote routine screening and early diagnosis, hence improving patient outcomes and expanding the market. These factors together with a strong emphasis on preventive healthcare position North America as a dominant region in the TFT market over the projection period.

Asia Pacific:

Asia-Pacific is the fastest growing region in the thyroid function test (TFT) market over the forecast period owing to rising thyroid health awareness and the incidence of thyroid illnesses. As public health campaigns and educational initiatives raise awareness about the necessity of thyroid function tests, an increasing number of people seek diagnosis and treatment for thyroid-related diseases. This expanding awareness is critical for early detection and management resulting in increased demand for TFTs throughout the region.

Furthermore, the increased frequency of thyroid illnesses such as hypothyroidism, hyperthyroidism and thyroid cancer is a major driver of market expansion in Asia Pacific. Changing lifestyles, dietary patterns and environmental variables all contribute to an increase in the prevalence of these illnesses. As more individuals suffer from thyroid-related health disorders, the demand for accurate and easily accessible diagnostic tests grows supporting the TFT market's rise.

Furthermore, the introduction of many novel tests for monitoring thyroid levels as well as the widespread adoption of important strategic initiatives are increasing market growth. Diagnostic technology advancements give more precise, reliable and cost-effective testing choices making it easier for healthcare providers to detect and manage thyroid diseases. Strategic partnerships, mergers and collaborations among key healthcare sector companies are also increasing the availability and use of advanced TFTs driving the market's rapid expansion in the Asia-Pacific region.

Global Thyroid Function Test Market: Segmentation Analysis

The Global Thyroid Function Test Market is segmented on the basis of Type of Test, End User, Application, and Geography.

Thyroid Function Test Market, By Type of Test

• Thyroid-Stimulating Hormone (TSH) Tests
• T4 (Thyroxine) Tests
• T3 (Triiodothyronine) Tests
• Thyroid Antibody Tests

Based on Type of Test, the market is Thyroid-Stimulating Hormone (TSH) Tests, T4 (Thyroxine) Tests, T3 (Triiodothyronine) Tests and Thyroid Antibody Tests. Thyroid-Stimulating Hormone (TSH) Tests dominate the thyroid function testing industry. TSH tests are critical for detecting and managing thyroid problems because they give a sensitive and accurate picture of thyroid function. They are frequently the first-line tests recommended by healthcare providers making them the most commonly utilized and necessary in clinical practice.

Thyroid Function Test Market, By End User

• Hospitals
• Diagnostic Laboratories
• Research Institutes

Based on End User, the market is divided into Hospitals, Diagnostic Laboratories, and Research Institutes. Thyroid function tests (TFTs) are mostly used by hospitals. Their extensive healthcare offerings, large patient volume and availability of advanced diagnostic facilities all contribute to their supremacy. Hospitals are frequently the principal sites for thyroid problem diagnosis, treatment and management assuring a continual need for TFTs in their everyday clinical processes.

Thyroid Function Test Market, By Application

• Hypothyroidism
• Hyperthyroidism
• Thyroid Nodules
• Thyroid Cancer

Based on Application, the market is segmented into Hypothyroidism, Hyperthyroidism, Thyroid Nodules and Thyroid Cancer. Hypothyroidism is the most common application in the thyroid function testing (TFT) market. This dominance is due to its widespread occurrence as well as the need for ongoing monitoring and treatment. Hypothyroidism necessitates frequent TFTs to properly adapt and manage treatment resulting in a continual demand for these tests in clinical settings.

Thyroid Function Test Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the World
• On the basis of Geography, the Global Thyroid Function Test Market is classified into North America, Europe, Asia Pacific and the Rest of the world. North America dominates the global thyroid function test (TFT) market due to broad test availability, competent healthcare providers, mandated newborn screening and low-cost cancer diagnostics. Meanwhile, Asia-Pacific is the fastest-growing region due to increased awareness, higher thyroid problem prevalence and advances in diagnostic tools. Strategic actions and public health campaigns drive up demand for TFTs in the Asia Pacific region.

Key Players

• The Global Thyroid Function Test study report will provide valuable insight with an emphasis on the global market. The major players in the market are Abbott Laboratories, Siemens Healthineers AG, Danaher Corporation, Roche Diagnostics, Thermo Fisher Scientific, Meridian Bioscience Inc., Beckman Coulter Inc., Omega Diagnostics Group plc and Bio-Rad Laboratories Inc.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share and market ranking analysis of the above-mentioned players globally.

• Thyroid Function Test Market Recent Developments
• In February 2021, Abbott Laboratories and Roche Diagnostics recently made waves with a research comparing their thyroid tests for subclinical hypothyroidism. The study discovered that Roche's free thyroxine and TSH assays produced much higher diagnostic results for subclinical hypothyroidism (SCH) than Abbott's thyroid assays.
• In May 2020, Eli Lilly and Company received approval from the U.S. Food and Drug Administration (FDA) for Retevmo, a treatment for Advanced or metastatic RET fusion-positive thyroid cancer, Advanced or metastatic RET-mutant medullary thyroid cancer (MTC) and Metastatic RET fusion-positive non-small cell lung cancer (NSCLC).

TABLE OF CONTENTS

1. Introduction

• Market Definition
• Market Segmentation
• Research Methodology

2. Executive Summary

• Key Findings
• Market Overview
• Market Highlights

3. Market Overview

• Market Size and Growth Potential
• Market Trends
• Market Drivers
• Market Restraints
• Market Opportunities
• Porter's Five Forces Analysis

4. Thyroid Function Test Market, By Type of Test

• Thyroid-Stimulating Hormone (TSH) Tests
• T4 (Thyroxine) Tests
• T3 (Triiodothyronine) Tests
• Thyroid Antibody Tests

5. Thyroid Function Test Market, By End User

• Hospitals
• Diagnostic Laboratories
• Research Institutes

6. Thyroid Function Test Market, By Application

• Hypothyroidism
• Hyperthyroidism
• Thyroid Nodules
• Thyroid Cancer

7. Regional Analysis

• North America
• United States
• Canada
• Mexico
• Europe
• United Kingdom
• Germany
• France
• Italy
• Asia-Pacific
• China
• Japan
• India
• Australia
• Latin America
• Brazil
• Argentina
• Chile
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE

8. Market Dynamics

• Market Drivers
• Market Restraints
• Market Opportunities
• Impact of COVID-19 on the Market

9. Competitive Landscape

• Key Players
• Market Share Analysis

10. Company Profiles

• Abbott Laboratories
• Siemens Healthineers AG
• Danaher Corporation
• Roche Diagnostics
• Thermo Fisher Scientific
• Meridian Bioscience, Inc.
• Beckman Coulter Inc.
• Omega Diagnostics Group plc
• Bio-Rad Laboratories, Inc.

11. Market Outlook and Opportunities

• Emerging Technologies
• Future Market Trends
• Investment Opportunities

12. Appendix

• List of Abbreviations
• Sources and References